The largest database of trusted experimental protocols

Superdex 200 column

Manufactured by GE Healthcare
Sourced in United States, Sweden, United Kingdom, Germany, Japan

The Superdex 200 column is a size-exclusion chromatography media used for the separation and purification of proteins, peptides, and other biomolecules. It is designed to provide efficient separation and high resolution across a wide range of molecular weights. The column is suitable for a variety of applications, including protein analysis, desalting, and buffer exchange.

Automatically generated - may contain errors

565 protocols using superdex 200 column

1

Recombinant Hemagglutinin Head Protein Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The globular head of H5 HA was expressed using the Bac-to-Bac baculovirus expression system (Invitrogen). The DNA fragment corresponding to residues D55 and E271 (F55-271) of the A/Anhui/1/2005 HA was inserted into a pFastBac dual vector (Invitrogen), with an N-terminal gp67 signal peptide to facilitate secretion and a C-terminal 6-His tag for purification. The recombinant bacmids were transfected into Sf9 insect cells using Cellfectin II Reagent (Invitrogen). Secreted globular head protein in the cell supernatants was captured by nickel-nitrilotriacetic acid (Ni-NTA) resin, eluted with 500 mM imidazole, and then further purified by size exclusion chromatography on a Superdex 200 column (GE Health Care). The Fab fragment was produced by digesting full-length 65C6, 100F4 and AVFluIgG03 IgG with papain for 5 h using Pierce Fab Preparation Kit (Thermo #44985) and further purified by gel filtration (Superdex 200 column, GE Health Care). The globular head and Fab complexes were generated by mixing the two components together, incubated on ice for 1 h and purified by size exclusion chromatography on a Superdex 200 column (GE Health Care).
+ Open protocol
+ Expand
2

Purification of RSV F Protein Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmids encoding prefusion RSV F (DS-Cav1), L141W, and D489Y variants and post-fusion (F ΔFP) proteins based on strain A2 were transfected into FreeStyle 293 F and Expi293 cells, respectively (Invitrogen, Carlsbad, CA, USA)32 (link), 34 (link). Proteins were expressed in the presence of kifunensine (5 μM) and were purified over Strep-Tactin resin (IBA, Goettingen, Germany). Prefusion RSV F (PRDM) protein36 (link) for DSF studies was purified from transiently transfected Expi293 cells using a two-step purification protocol including cation-exchange chromatography at pH 5.0 (HiTrap Capto SP ImpRes column; GE Healthcare Biosciences, Pittsburgh, PA, USA) and size-exclusion chromatography using a Superdex 200 column (GE Healthcare). For crystallization studies, purification tags were removed by overnight digestion with thrombin followed by gel filtration using a Superose 6 column (GE Healthcare Biosciences) with a running buffer of 2 mM TRIS pH 8.0, 200 mM NaCl. For ITC studies, tags were not removed and proteins were purified by gel filtration using a Superdex 200 column (GE Healthcare) with a running buffer of PBS.
+ Open protocol
+ Expand
3

Structural Analysis of Influenza Antibody

Check if the same lab product or an alternative is used in the 5 most similar protocols
The purified FLD21.140 IgG was digested using papain from papaya latex (P3125; Sigma) at 37 °C for 12 h, and the digested Fab and Fc fragments were separated by loading the mixture onto a protein A column. The Fab fragment was collected in the flow-through, and the Fc fragment was captured on the protein A beads. The flow-through was further purified by gel filtration (Superdex 200 column, GE Healthcare). The purified globular heads (A/Thailand/1(KAN-1)/2004) and FLD21.140 Fab were mixed at a molar ratio of 1:1, incubated at 4 °C for 1 h, and then purified by gel-filtration chromatography on a Superdex 200 column (GE Healthcare). For crystallization, the globular head–FLD21.140 Fab complex was concentrated to 20 mg/ml in HBS buffer. Crystals were successfully grown at 18 °C using the vapor diffusion method in sitting drops, which consisted of equal volumes of protein and reservoir solution containing 2.0 m (NH4)2SO4 and 0.1 m BisTris, pH 5.5. All crystals were cryoprotected by soaking in reservoir solution with 20% v/v glycerol for several seconds and then frozen in liquid nitrogen before data collection. Diffraction data were collected on the BL17U beamline at the Shanghai Synchrotron Research Facility (SSRF) (65 ) and processed using the program HKL2000 (66 (link)). All data collection and processing statistics are listed in Table S2.
+ Open protocol
+ Expand
4

Purification of TcpA Protein from Inclusion Bodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
The bulk of TcpA-C (about 90%) was detected in inclusion bodies. The remaining ~10% of the protein population localized to the soluble fraction of cell lysate and was purified in two steps: (1) by affinity chromatography on Ni-NTA resin (Profinia™ Affinity Chromatography Protein Purification System; Bio-Rad Laboratories, Inc., Hercules, CA, USA), followed by (2) size-exclusion chromatography on a Superdex 200 column (GE Healthcare, Chicago, IL, USA), as described elsewhere [17 (link)]. At the first stage of purification, the soluble fraction of cell lysate was applied to the Ni-NTA column. Washing was carried out using Native IMAC Wash Buffer (Bio-Rad Laboratories, Inc., Hercules, CA, USA) with stepwise increasing concentrations of imidazole—30 mM (10.0 mL), 50 mM (10.0 mL), and 100 mM (10.0 mL)—to reduce nonspecific binding of contaminating proteins to the sorbent and increase the purity of the TcpA protein. Native IMAC Elution Buffer (Bio-Rad Laboratories, Inc., Hercules, CA, USA) with 250 mM imidazole was used in elution. At the second stage, size-exclusion chromatography on a Superdex 200 column (GE Healthcare, Chicago, IL, USA) used 20 mM Tris-HCl buffer, pH 8.9, and 150 mM NaCl. The peak containing the protein of interest with Mr of about 20 kDa was collected, concentrated up to 0.5 mg/mL, and used for the subsequent analysis.
+ Open protocol
+ Expand
5

Engineered Nanobody-Fc Antibody Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The dimer constructs (DR14 and DS43) were engineered via fusing nanobody to hFc. The homo-trimer versions of R14 and S43 (TR14 and TS43) were constructed via head-to-tail with (GGGGS)3 linkers and a C-terminal His-tag. The coding sequence of R14 or S43 fused to the Fc of human IgM was cloned into the pCAGGS vector to generate IgM versions of the antibodies (MR14 and MS43). The coding sequence of TR14 was synthesized by Nanjing GenScript Biotech Co., Ltd., and TS43 was synthesized by Tsingke Biotechnology Co., Ltd. DR14 and DS43 were expressed in Freestyle 293F cells and were purified using a HiTrap Protein A 5-mL column (GE Healthcare) and Superdex 200 column (GE Healthcare). TR14 and TS43 were expressed in Freestyle 293F cells and were purified using a HisTrap EXCEL 5-mL column (GE Healthcare) and Superdex 200 column (GE Healthcare). The recombinant plasmid for MR14 or MS43 and a human J-chain expressing vector were co-transfected into Freestyle 293F cells to express the MR14 or MS43 proteins, which were further purified by HiTrap™ IgM Purification HP (GE Healthcare) and Superose 6 Increase 10/300 GL (GE Healthcare) chromatography.
+ Open protocol
+ Expand
6

Assembling Csy-AcrIF Complexes for CRISPR Interference

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assemble Csy-AcrIF complexes, purified Csy was incubated with AcrIF proteins at a molar ratio of 1:10 for 1 h on ice, and then subjected to size exclusion chromatography over a Superdex 200 column (GE Healthcare) equilibrated in buffer containing 20 mM HEPES (pH 7.5), 100 mM KCl, 5% glycerol and 1 mM TCEP, followed by SDS-PAGE analysis of the elution fractions.
To test whether AcrIF4, AcrIF7 and AcrIF14 can interact with the Csy complex simultaneously, Csy, AcrIF4, AcrIF7 and AcrIF14 were incubated at molar ratio of 1:3:3:3 for 1 h on ice, and then subjected to size exclusion chromatography over a Superdex 200 column (GE Healthcare) equilibrated in buffer containing 50 mM HEPES (pH 7.5), 100 mM KCl, 5% glycerol and 1 mM TCEP, followed by SDS-PAGE analysis of the elution fractions.
+ Open protocol
+ Expand
7

Deglycosylation and Crystallization of gp120-DH650 Complex

Check if the same lab product or an alternative is used in the 5 most similar protocols
CH505 gp120 core (residues 44-492, ΔV1-V2 and ΔV3) (128 (link)) was expressed in HEK293S GnTI cells and purified by affinity chromatography on Galanthus nivelis lectin (Vector Laboratories) followed by gel filtration on Superdex 200 column (GE). Deglycosylation was carried out with endoglycosidase H (New England biolabs) in deglycosylation buffer (50 mM sodium acetate, pH 6, 5 mM EDTA, 500 mM NaCl, 10uL endoH, 1 μg/μl leupeptin, 1 μg/μl aprotonin) at 37° overnight, followed by buffer exchange to 40 mM Tris HCl, pH 7.4, 1 M NaCl, 2 mM MnCl2, 2 mM CaCl2 and passage through a concanavalin A column (Sigma) to remove any gp120 that had not been fully deglycoylated by the endoH treatment. The eluate was buffer exchanged by passage over a Superdex200 column (GE) into 2.5mM Tris-HCl pH7.5, 350mM NaCl, followed by concentration to 4mg/ml. The Fab fragment of mAb DH650 was expressed in HEK293T cells, as described (128 (link)). DH650-gp120 core complex was formed by incubating gp120 core with DH650 in 1:1.3 molar ratio followed by gel filtration on Superdex 200 (GE) column in buffer 2.5mM Tris-HCl pH 7.5, 350mM NaCl. The complex was concentrated to 8.5 mg/ml and crystallized by hanging-drop vapor diffusion in 20% PEG 8K, 100mM Tris pH 8, 500mM NaCl.
+ Open protocol
+ Expand
8

Analytical SEC of mCherry-p62 Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
For analytical SEC, 200 µg of the mCherry-p62 variants were applied to a Superose 6
column (10/300, GE Healthcare) or Superdex 200 column (10/300, GE Healthcare) and
eluted with 25 mM HEPES pH 7.5, 500 mM NaCl, 1mM DTT. 25 µL of 0.5 mL fractions were
run on a 4-–20% SDS-PAGE gel (Biorad, Hercules, CA, USA) and stained with Coomassie.
SLS analysis was done with a Superdex 200 column (10/300, GE Healthcare). Online
Multi-Angle Laser Light Scattering detection was performed with a MiniDawn Treos
detector (Wyatt Technology, Santa Barbara, CA, USA) via a laser emitting at 690 nm
and by refractive index measurement using a Shodex RI-101 (Shodex, Munich,
Germany).
+ Open protocol
+ Expand
9

Purification of Key Cytoskeletal Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fibronectin was purified from human plasma by gel filtration and affinity chromatography over a Sepharose CL-4B column (Sigma), followed by a gelatin Sepharose column from GE Healthcare (Munich, Germany). Subsequently, fibronectin was eluted by 6 M urea (Sigma) in PBS and dialyzed against PBS before use.
Actin was isolated from an acetone powder of rabbit skeletal muscle in G-buffer by modifying the protocol of Spudich and Watt. 35 Actin was polymerized by adding 50 mM KCl and 2 mM MgCl 2 (Carl Roth). Subsequently, KCl and MgCl 2 were removed by dialyzation with G-buffer, and the depolymerized actin was purified by gel filtration with a Superdex 200 column (GE Healthcare) and stored in G-buffer. According to the protocol of Margossian and Lowey we also isolated myosin II from rabbit skeletal muscle using centrifugation and salting out. 36 The purified myosin was diluted in D-buffer. a-Actinin was isolated from chicken gizzard following the protocol of Craig et al. 37 After extraction with 1 mM KHCO 3 a-actinin was salted out with (NH 4 ) 2 SO 4 (Carl Roth) and purified with ion exchange chromatography over a DEAE column (GE Healthcare) and gel filtration with a Superdex 200 column. Isolated a-actinin was stored in A-buffer.
+ Open protocol
+ Expand
10

Gel Filtration Analysis of PTP1B-Inhibitor Complex

Check if the same lab product or an alternative is used in the 5 most similar protocols
PTP1B (5 μM) was incubated with 10 μM MSI-1436 in a final volume of 200 μl buffer (50 mM HEPES pH7.0, 100 mM NaCl, 0.2 mM EDTA, 2 mM DTT) at 4 C. The reaction mixture was then subjected to gel filtration on a Superdex 200 column (HR30/10; Pharmacia Biotech Inc.). Prior to loading the MSI-1436-saturated protein sample, the column was equilibrated with 50 mM HEPES pH 7.0, 100 mM NaCl, 0.2 mM EDTA, 2 mM DTT containing 100 μM MSI-1436 to ensure the protein is bound to the inhibitor throughout the run. The void volume (Vo) and total volume (Vt) were measured using blue dextran and Commassie blue dye respectively. Fractions of 0.5 ml were collected and the protein concentration in each sample was determined by Bradford assay or recording the UV absorption spectrum at 280 nm. Alternatively, the fractions were precipitated with 10% trichloroacetic acid, and subjected to SDS-PAGE followed by staining of the gel with Coomassie blue. Relative retention (Rt) was determined from the absolute retention volumes (Vabs) according to the equation
Rt=(Vabs-Vo)/(Vtot-Vo) . The column was calibrated with ferritin, catalase, cytochrome C and BSA as molecular weight standards.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!